{"id":"tetracycline-pill","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Photosensitivity"},{"rate":"5-15","effect":"Nausea and vomiting"},{"rate":"1-5","effect":"Esophageal irritation"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"1-5","effect":"Vaginal candidiasis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tetracyclines are broad-spectrum antibiotics that work by blocking the attachment of aminoacyl-tRNA to the bacterial ribosome, thereby halting translation of bacterial proteins. This bacteriostatic mechanism is effective against a wide range of gram-positive and gram-negative bacteria, as well as some atypical organisms like Chlamydia and Mycoplasma. The drug is also used off-label at sub-antimicrobial doses for anti-inflammatory effects in conditions like rosacea and acne.","oneSentence":"Tetracycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing peptide bond formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:12:02.169Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (respiratory, urinary, skin, and soft tissue infections)"},{"name":"Acne vulgaris"},{"name":"Rosacea"}]},"trialDetails":[{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05072093","phase":"PHASE4","title":"Parrying the Pitfalls of PrEP: Project PEACH","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-11-20","conditions":"HIV, STI","enrollment":240},{"nctId":"NCT02719392","phase":"PHASE4","title":"A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression","status":"SUSPENDED","sponsor":"Massachusetts General Hospital","startDate":"2017-08-09","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":40},{"nctId":"NCT06414408","phase":"EARLY_PHASE1","title":"Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-10-18","conditions":"Sexually Transmitted Diseases, Bacterial","enrollment":48},{"nctId":"NCT06044090","phase":"PHASE4","title":"Brain and Stress Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-09-12","conditions":"Stress, Psychological, Motivation","enrollment":10},{"nctId":"NCT06509139","phase":"PHASE4","title":"Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males","status":"ENROLLING_BY_INVITATION","sponsor":"National Cheng-Kung University Hospital","startDate":"2024-07-09","conditions":"Helicobacter Pylori Infection, Sex, Bismuth Quadruple Therapy","enrollment":661},{"nctId":"NCT04762134","phase":"NA","title":"Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)","status":"RECRUITING","sponsor":"Jonathan Troy Grennan","startDate":"2023-06-02","conditions":"Bacterial Sexually Transmitted Diseases","enrollment":560},{"nctId":"NCT04527055","phase":"PHASE4","title":"The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication","status":"ENROLLING_BY_INVITATION","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Dysbiosis, Probiotics","enrollment":312},{"nctId":"NCT01283997","phase":"PHASE2","title":"Prevention of Treatment Induced Neuropathy in Multiple Myeloma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-01-25","conditions":"Myeloma","enrollment":79},{"nctId":"NCT04210713","phase":"PHASE1","title":"Neuroimmune Dysfunction in Alcohol Use Disorder","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-02-03","conditions":"Alcohol Drinking, Alcohol-Related Disorders, Disease","enrollment":142},{"nctId":"NCT00066027","phase":"PHASE3","title":"Effects of Low-Dose Doxycycline on Oral Bone Loss","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2002-06-01","conditions":"Periodontitis","enrollment":128},{"nctId":"NCT02055963","phase":"PHASE2","title":"Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-05-06","conditions":"Head And Neck Cancer","enrollment":30},{"nctId":"NCT01744093","phase":"NA","title":"Doxycycline for COPD in HIV-Infected Patients","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2014-12-08","conditions":"HIV, Chronic Obstructive Pulmonary Disease (COPD), Emphysema","enrollment":61},{"nctId":"NCT02756403","phase":"NA","title":"A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2016-03","conditions":"First Trimester Abortion","enrollment":181},{"nctId":"NCT01468831","phase":"PHASE1, PHASE2","title":"Minocycline to Treat Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2012-03-28","conditions":"Retinal Vein Occlusion","enrollment":9},{"nctId":"NCT02998151","phase":"EARLY_PHASE1","title":"Neurophysiological and Acute Pharmacological Studies in FXS Patients","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2016-01","conditions":"Fragile X Syndrome","enrollment":29},{"nctId":"NCT01793051","phase":"PHASE2","title":"Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-03-22","conditions":"Myeloma","enrollment":88},{"nctId":"NCT01173692","phase":"PHASE2","title":"Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-07-22","conditions":"Oropharynx Cancer","enrollment":47},{"nctId":"NCT01658995","phase":"PHASE3","title":"Management of Etonogestrel Subdermal Implant-related Bleeding","status":"COMPLETED","sponsor":"Petra M. Casey","startDate":"2012-09-13","conditions":"ESI-related Bleeding","enrollment":82},{"nctId":"NCT01469585","phase":"NA","title":"Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases","status":"COMPLETED","sponsor":"University of Hawaii","startDate":"2011-11","conditions":"Breakthrough Bleeding","enrollment":20},{"nctId":"NCT02456948","phase":"PHASE2","title":"Adjunct Minocyline in Treatment-resistant Depression","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2015-01","conditions":"Major Depressive Disorder","enrollment":168},{"nctId":"NCT03117530","phase":"PHASE1","title":"Measuring Brain Inflammation in Autism","status":"SUSPENDED","sponsor":"University of California, Los Angeles","startDate":"2017-04-11","conditions":"Autism Spectrum Disorder","enrollment":30},{"nctId":"NCT01636934","phase":"PHASE2","title":"Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-07","conditions":"Lung Cancer","enrollment":51},{"nctId":"NCT01693523","phase":"PHASE2","title":"Minocycline Study in Pancreatic Cancer Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01-28","conditions":"Pancreatic Cancer","enrollment":80},{"nctId":"NCT02359006","phase":"NA","title":"The Effects of Minocycline in Opioid-maintained Patients","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-03-12","conditions":"Opioid Dependence, Pain","enrollment":27},{"nctId":"NCT01317550","phase":"NA","title":"A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-07","conditions":"Lung Cancer","enrollment":14},{"nctId":"NCT02753426","phase":"PHASE1","title":"A Trial of Doxycycline in Renal Disease","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-04","conditions":"Chronic Kidney Disease, Cardiorenal Syndrome","enrollment":11},{"nctId":"NCT01375491","phase":"PHASE4","title":"Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2009-10","conditions":"Type 2 Diabetes, Obesity","enrollment":39},{"nctId":"NCT01695291","phase":"PHASE2","title":"Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2012-05","conditions":"Obsessive Compulsive Disorder","enrollment":31},{"nctId":"NCT02193269","phase":"PHASE1","title":"The Effects of Minocycline in Humans","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-07-08","conditions":"Memory Impairment","enrollment":10},{"nctId":"NCT01433055","phase":"NA","title":"Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2011-07","conditions":"Schizophrenia","enrollment":52},{"nctId":"NCT02362529","phase":"EARLY_PHASE1","title":"Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":115},{"nctId":"NCT03768557","phase":"NA","title":"The Effect of Acute Minocycline Administration on Emotional Processing and Cognition in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2017-04-26","conditions":"Mood, Cognitive Change","enrollment":40},{"nctId":"NCT00322465","phase":"PHASE2","title":"NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-11","conditions":"Urethritis","enrollment":305},{"nctId":"NCT03244592","phase":"PHASE1, PHASE2","title":"Minocycline for Alcohol Use Disorder","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2018-01-15","conditions":"Alcohol Use Disorder, Inflammation, Neurocognitive Dysfunction","enrollment":""},{"nctId":"NCT01798225","phase":"PHASE4","title":"Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-12","conditions":"Periodontal Disease, Type 2 Diabetes Mellitus","enrollment":113},{"nctId":"NCT01746043","phase":"PHASE2","title":"A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-02","conditions":"Esophageal Cancer","enrollment":22},{"nctId":"NCT02569437","phase":"PHASE2","title":"Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-09","conditions":"Polyp of Nasal Sinus","enrollment":49},{"nctId":"NCT00246740","phase":"PHASE2","title":"Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2005-10","conditions":"Coronary Artery Bypass Grafting, Cardiopulmonary Bypass, Reperfusion Injury","enrollment":56},{"nctId":"NCT01053156","phase":"NA","title":"Trial of Minocycline to Treat Children With Fragile X Syndrome","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2010-01","conditions":"Fragile X Syndrome","enrollment":66},{"nctId":"NCT02388477","phase":"NA","title":"Trial of the Use of Doxycycline After Rotator Cuff Repair","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"","conditions":"Rotator Cuff Injury","enrollment":""},{"nctId":"NCT01788215","phase":"PHASE3","title":"Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2010-11","conditions":"Polycystic Ovarian Syndrome (PCOS), Irregular Menstrual Cycles, Androgen Excess","enrollment":10},{"nctId":"NCT02056665","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome","status":"COMPLETED","sponsor":"Puerta de Hierro University Hospital","startDate":"2014-01","conditions":"Angelman Syndrome","enrollment":32},{"nctId":"NCT00480532","phase":"NA","title":"A Study of Continuous Oral Contraceptives and Doxycycline","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2007-05","conditions":"Contraceptives, Oral","enrollment":131},{"nctId":"NCT01120899","phase":"PHASE1, PHASE2","title":"A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2010-04","conditions":"Diabetic Macular Edema","enrollment":6},{"nctId":"NCT01886560","phase":"PHASE2, PHASE3","title":"Low Dose Doxycycline in the Treatment of Corneal Burn","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2013-09","conditions":"Eye Burns","enrollment":40},{"nctId":"NCT00930020","phase":"PHASE4","title":"Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial","status":"TERMINATED","sponsor":"Singhealth Foundation","startDate":"2009-07","conditions":"Acute Stroke","enrollment":139},{"nctId":"NCT00066066","phase":"PHASE2","title":"Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers","status":"COMPLETED","sponsor":"The Forsyth Institute","startDate":"2003-07","conditions":"Periodontitis, Periodontal Diseases","enrollment":146},{"nctId":"NCT00277355","phase":"PHASE2, PHASE3","title":"Pilot Study of Minocycline in Huntington's Disease","status":"COMPLETED","sponsor":"Merit Cudkowicz","startDate":"2006-04","conditions":"Huntington Disease","enrollment":114},{"nctId":"NCT00893724","phase":"NA","title":"Supplemental Adjuvants for Intracellular Nutrition and Treatment","status":"UNKNOWN","sponsor":"Mid-Atlantic Retina Consultations, Inc.","startDate":"2009-06","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema","enrollment":60},{"nctId":"NCT01205464","phase":"NA","title":"Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis","status":"COMPLETED","sponsor":"Linkoeping University","startDate":"2005-02","conditions":"Fatigue, Radicular Pain, Cognitive Dysfunction","enrollment":15},{"nctId":"NCT00916461","phase":"PHASE1, PHASE2","title":"Role of Minocycline in First Episode Psychosis","status":"COMPLETED","sponsor":"Stanley Medical Research Institute","startDate":"2006-05","conditions":"First Episode Psychosis","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":62,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tetracycline (250 mg)"],"phase":"marketed","status":"active","brandName":"Tetracycline Pill","genericName":"Tetracycline Pill","companyName":"National Cheng-Kung University Hospital","companyId":"national-cheng-kung-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tetracycline is a small molecule that inhibits the bacterial 70S ribosome, classified as an inhibitor. It is used to treat various conditions, including Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, and Periodontitis, among others.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}